» Articles » PMID: 37370722

Sex Differences in Lung Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jun 28
PMID 37370722
Authors
Affiliations
Soon will be listed here.
Abstract

Sex disparities in the incidence and mortality of lung cancer have been observed since cancer statistics have been recorded. Social and economic differences contribute to sex disparities in lung cancer incidence and mortality, but evidence suggests that there are also underlying biological differences that contribute to the disparity. This review summarizes biological differences which could contribute to the sex disparity. Sex hormones and other biologically active molecules, tumor cell genetic differences, and differences in the immune system and its response to lung cancer are highlighted. How some of these differences contribute to disparities in the response to therapies, including cytotoxic, targeted, and immuno-therapies, is also discussed. We end the study with a discussion of our perceived future directions to identify the key biological differences which could contribute to sex disparities in lung cancer and how these differences could be therapeutically leveraged to personalize lung cancer treatment to the individual sexes.

Citing Articles

An analysis of the burden of respiratory tract cancers in global, China, the United States and India: findings based on the GBD 2021 database.

Liu X, Wang G, Chen Y, Ma S, Huang B, Song S BMC Public Health. 2025; 25(1):945.

PMID: 40065230 PMC: 11895191. DOI: 10.1186/s12889-025-21979-y.


Identifying Sex Differences in Lung Adenocarcinoma Using Multi-Omics Integrative Protein Signaling Networks.

Chen C, Saha E, Fischer J, Ben Guebila M, Fanfani V, Shutta K bioRxiv. 2025; .

PMID: 39975108 PMC: 11838606. DOI: 10.1101/2025.02.03.636354.


ERS Congress 2024: highlights from the Thoracic Surgery and Lung Transplantation Assembly.

Esendagli D, Mastromarino M, Valverde Zuniga A, Migliore M, Meloni F ERJ Open Res. 2025; 11(1).

PMID: 39872383 PMC: 11770695. DOI: 10.1183/23120541.01046-2024.


Is FDG-PET/CT Scan Useful in the Detection of Subcentimeter Mediastinal Lymph Node Involvement in Patients With Lung Carcinoma?.

Altaf M, Zahra H, Majied H, Niazi I, Farooq H Cureus. 2024; 16(11):e74572.

PMID: 39735116 PMC: 11680465. DOI: 10.7759/cureus.74572.


Association Between Incense Burning and the Risk of Lung Cancer in Asian Population: Meta-Analysis of Nine Case-Control Studies.

Tang H, Voon F, Sim E Cancer Rep (Hoboken). 2024; 7(12):e70095.

PMID: 39725665 PMC: 11671240. DOI: 10.1002/cnr2.70095.


References
1.
Roden A, Moser M, Tri S, Mercader M, Kuntz S, Dong H . Augmentation of T cell levels and responses induced by androgen deprivation. J Immunol. 2004; 173(10):6098-108. DOI: 10.4049/jimmunol.173.10.6098. View

2.
Wheldon C, Wiseman K . Tobacco Use Among Transgender and Gender Non-conforming Adults in the United States. Tob Use Insights. 2019; 12:1179173X19849419. PMC: 6535756. DOI: 10.1177/1179173X19849419. View

3.
Weinberg O, Marquez-Garban D, Fishbein M, Goodglick L, Garban H, Dubinett S . Aromatase inhibitors in human lung cancer therapy. Cancer Res. 2005; 65(24):11287-91. DOI: 10.1158/0008-5472.CAN-05-2737. View

4.
Kazmi N, Marquez-Garban D, Aivazyan L, Hamilton N, Garon E, Goodglick L . The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manag. 2013; 1(4):259-272. PMC: 3643508. DOI: 10.2217/lmt.12.44. View

5.
Cheng Y, Rath E, Linton A, Yuen M, Takahashi K, Lee K . The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer. Lung Cancer (Auckl). 2020; 11:1-11. PMC: 6955579. DOI: 10.2147/LCTT.S186843. View